Federal prosecutors in Manhattan are investigating claims that Pfizer delayed its COVID-19 vaccine success announcement until after the 2020 U.S. presidential election. According to a March 2025 Wall Street Journal report, the allegations stem from British drugmaker GSK, based on statements attributed to Philip Dormitzer, GSK’s former vaccine development head and ex-Pfizer employee.
On May 15, 2025, House Judiciary Committee Chair Jim Jordan and Judiciary GOP highlighted new allegations via X posts. They claimed Pfizer executives intentionally withheld clinical trial data to sway the 2020 election. Posts from.
I can’t keep doing my independent journalism without your support.
The Wall Street Journal reported that prosecutors have interviewed two individuals, including a GSK executive who documented a conversation with Dormitzer. More interviews are planned, but Pfizer officials have not been questioned. Pfizer denied any delay, telling Reuters it worked transparently to secure FDA Emergency Use Authorization as quickly as possible.
Dormitzer refuted the allegations, stating to Reuters that he and Pfizer colleagues pushed for the earliest possible authorization. Former President Trump has made similar claims about a delay, but no evidence supports these accusations.
The investigation is ongoing, with no confirmed evidence of misconduct by Pfizer. GSK declined to comment, and the Manhattan U.S. Attorney’s Office has not publicly addressed the probe.
